Mark Prichard PhD

Dr. Prichard received his Ph.D. from the University of Michigan in the Department of Microbiology and Immunology. He did his postdoctoral training in the laboratory of Dr. Ed Mocarski at Stanford University. He then spent several years in the biotech industry and was involved in the development of Flumist while employed at MedImmune Vaccines Inc. He is a Professor of Pediatrics at the University of Alabama at Birmingham where he is also the Director of the Diagnostic Virology Laboratory. He is an Editor of the journal, Antiviral Research, and is coauthor of more than 80 publications, book chapters and review articles, as well as the MacSynergy II analytical software. Current research interests include the discovery of antiviral drugs for DNA viruses and defining their activity at the molecular level